How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison?

Here, Mtech Access are joined by experts from Arcturis and Delta Hat. Dan Howard (Associate Director – Health Economics, Mtech Access) shares some of the challenges that our clients face when developing HTA-ready health economic models with limited clinical trial data. Joseph O’Reilly (Principal Medical Statistician, Arcturis) introduces solutions to these challenges using RWD and RWE approaches. Nick Latimer (Analyst, Delta Hat; Professor of Health Economics, University of Sheffield; former NICE Appraisal Committee member) discusses how RWE is assessed by HTA committees. Samantha Gillard (Director – HTA, Mtech Access) facilitates the discussion and puts your questions to our experts

This episode was first broadcast as a live webinar in October 2024. To request a copy of the slides used or to learn more visit: https://mtechaccess.co.uk/rwe-approaches-economic-modelling-hta/

For support with real-world evidence analysis, health economic modelling of health technology assessment, email info@mtechaccess.co.uk or visit https://mtechaccess.co.uk/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Mtech Access - Powered by Petauri. Innehållet i podden är skapat av Mtech Access - Powered by Petauri och inte av, eller tillsammans med, Poddtoppen.